119
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Development of a Directly Compressible Poly(Ethylene Oxide) Matrix for the Sustained-Release of Dihydrocodeine Bitartrate

, , Ph.D. & , Ph.D.
Pages 1045-1052 | Published online: 17 Nov 2003

References

  • Roider G., Drasch G., Von Meyer L., Eisenmenger W. Use of dihydrocodeine as illicit drug substitute. Pharm. Zeit. 1996; 141: 11–21
  • Wilder-Smith C.H., Hill L., Spargo K., Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomized study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001; 91: 23–31
  • Johnson M.A., Woodcock A.A., Geddes D.M. Dihydrocodeine for breathlessness in pink puffers. Br. Med. J. 1983; 286: 675–677
  • Morita K., Kamei J. Involvement of ATP-sensitive K+ channels in the anti-tussive effect of moguisteine. Eur. J. Pharmacol. 2000; 395: 161–164
  • Goldie R.S., Malkowska S.T.A., Leslie S.T., Miller R.B. Controlled Release Dihydrocodeine Composition. US Patent 4,834,984, May 30, 1989
  • Freye E., Baranowski J., Latasch L. Dose-related effects of controlled release dihydrocodeine on oro-cecal transit and pupillary light reflex. A study in human volunteers. Arzneimittelforschung 2001; 51: 60–66
  • Bhardwaj T.R., Kanwar M., Lal R., Gupta A. Natural gums and modified natural gums as sustained-release carriers. Drug Dev. Ind. Pharm. 2000; 26(10)1025–1038
  • Kumar M.N.V.R., Kumar N. Polymeric controlled drug-delivery systems: perspective issues and opportunities. Drug Dev. Ind. Pharm. 2001; 27(1)1–30
  • Apicella A., Cappello B., Del Nobile M.A., La Rotonda M.I., Mensitieri G., Nicolais L. Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release. Biomaterials 1993; 14(2)83–90
  • Zhang F., McGinity J.W. Properties of sustained-release tablets prepared by hot-melt extrusion. Pharm. Dev. Tech. 1999; 4(2)241–250
  • Razaghi A.M., Schwartz J.B. Investigation of cyclobenzaprine hydrochloride release from oral osmotic delivery systems containing a water-swellable polymer. Drug Dev. Ind. Pharm. 2002; 28(6)631–639
  • Rudnic E.M., Kottke M.K. Tablet Dosage Forms. Modern Pharmaceutics, 3rd Ed., G.S. Banker, C.T. Rhodes. Marcel Dekker, Inc., New York 1995; 333–394
  • Kim C.-J. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from polyox® tablets. Drug Dev. Ind. Pharm. 1998; 24(7)645–651
  • Ritger P.L., Peppas N.A. A Simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Rel. 1987; 5: 37–42
  • Lee P.I. Kinetics of drug release from hydrogel matrices. J. Control. Rel. 1985; 2: 277–288
  • Khan K.A. The concept of dissolution efficiency. J. Pharm. Pharmacol. 1975; 27: 48–49
  • Rowell F.J., Seymour R.A., Rawlins M.D. Pharmacokinetics of intravenous and oral dihydrocodeine and its acid metabolites. Eur. J. Clin. Pharmacol. 1983; 25: 419–424

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.